Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12612]

ASCO 2015: Adding elotuzumab significantly reduces risk of progression for relapsed multiple myeloma

ASCO 2015: Adding elotuzumab significantly reduces risk of progression for relapsed multiple myeloma

ASCO 2015: Simple oral vitamin reduces risk of common, non-melanoma skin cancers

ASCO 2015: Simple oral vitamin reduces risk of common, non-melanoma skin cancers

Positive CHMP opinion recommends ibrutinib for the treatment of Waldenström’s macroglobulinemia

Positive CHMP opinion recommends ibrutinib for the treatment of Waldenström’s macroglobulinemia

Attitudes and beliefs about complementary and alternative medicine predict use among patients with cancer

Attitudes and beliefs about complementary and alternative medicine predict use among patients with cancer

Stabilised mutant p53 is an important determinant of tumour survival and a valid drug target

Stabilised mutant p53 is an important determinant of tumour survival and a valid drug target

Next generation sequencing-based tumour genomic profiling aids in detecting hereditary variants in cancer risk genes

Next generation sequencing-based tumour genomic profiling aids in detecting hereditary variants in cancer risk...

King's Oncology Summer School launched with leading cancer centre in India

King's Oncology Summer School launched with leading cancer centre in India

Smoking induces early signs of cancer in cheek swabs

Smoking induces early signs of cancer in cheek swabs

Novel insights in MET-proto-oncogene might lead to optimising cancer treatment

Novel insights in MET-proto-oncogene might lead to optimising cancer treatment

Mortality and incidence for most breast cancer subtypes continue to decline

Mortality and incidence for most breast cancer subtypes continue to decline

More from ecancer